DENVER--(BUSINESS WIRE)--MPEG LA, LLC, world leader in alternative one-stop patent licenses, testified today at a public hearing on Genetic Diagnostic Testing at the US Patent and Trademark Office to introduce Librassay®, a market-based solution addressing genetic diagnostic patent licensing issues of concern to the panel. Through a patent licensing “supermarket” making essential patent rights available on a nonexclusive, nondiscriminatory basis, Librassay® will accelerate adoption and availability of genetic diagnostic tests leading to personalized medical solutions in service to the entire market.
